Aurora B Recombinant Rabbit Monoclonal Antibody [SC55-08]
cat.: ET1610-25
Product Type: Recombinant Rabbit monoclonal IgG, primary antibodies
Species reactivity: Human
Applications: WB, IHC-P, IP, IF-Cell
Clonality: Monoclonal
Clone number: SC55-08
Form: Liquid
Storage condition: Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles.
Storage buffer: 1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Concentration: 1ug/ul
Purification: Protein A affinity purified.
Molecular weight: Predicted band size: 39 kDa
Isotype: IgG
Immunogen: Synthetic peptide within Human Aurora B aa 1-50 / 344.
Positive control: Hela cell lysate, MCF-7 cell lysate, human tonsil tissue, HeLa.
Subcellular location: Nucleus, Cytoplasm, Chromosome.
Recommended Dilutions:
  WB
  IHC-P
  IF-Cell

1:1,000-1:2,000
1:50-1:200
1:100
Uniprot #: SwissProt: Q96GD4 Human | O70126 Mouse | O55099 Rat
Alternative names: AIK2 AIM-1 AIM1 ARK-2 ARK2 AurB AURKB AURKB_HUMAN Aurora 1 Aurora and Ipl1 like midbody associated protein 1 Aurora kinase B Aurora related kinase 2 Aurora- and Ipl1-like midbody-associated protein 1 Aurora-B Aurora-related kinase 2 Aurora/IPL1 related kinase 2 Aurora/IPL1-related kinase 2 IPL1 PPP1R48 Protein phosphatase 1 regulatory subunit 48 Serine/theronine kinase 12 Serine/threonine protein kinase 12 Serine/threonine-protein kinase 12 Serine/threonine-protein kinase aurora-B STK-1 STK1 STK12 STK5
Images
ET1610-25_1.jpg Fig1: Western blot analysis of Aurora B on different lysates using anti-Aurora B antibody at 1/1,000 dilution.
Positive control:
Lane 1: Hela cell lysates
Lane 2: MCF-7 cell lysates
ET1610-25_2.jpg Fig2: All lanes: Western blot analysis of Aurora B with anti-Aurora B antibody (ET1610-25) at 1:500 dilution.
Lane 1: Wild-type Hela whole cell lysate (10 µg).
Lane 2: Aurora B knockdown Hela whole cell lysate (10 µg).

ET1610-25 was shown to specifically react with Aurora B in wild-type Hela cells. Weakened band was observed when Aurora B knockdown sample was tested. Wild-type and Aurora B knockdown samples were subjected to SDS-PAGE. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM in TBST for 1 hour at room temperature. The primary antibody (ET1610-25, 1:500) was used in 5% BSA at room temperature for 2 hours. Goat Anti-Rabbit IgG-HRP Secondary Antibody (HA1001) at 1:200,000 dilution was used for 1 hour at room temperature.
ET1610-25_3.jpg Fig3: Immunohistochemical analysis of paraffin-embedded human tonsil tissue using anti-Aurora B antibody. Counter stained with hematoxylin.
ET1610-25_4.jpg Fig4: Immunocytochemistry analysis of HeLa cells labeling Aurora B with Rabbit anti-Aurora B antibody (ET1610-25) at 1/100 dilution.

Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Aurora B antibody (ET1610-25) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Note: All products are “FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE”.